[Lipoprotein (a)--link between lipid metabolism and coagulation system?].

Area of Science:

• Biochemistry and Molecular Biology
• Cardiovascular Research
• Lipid Metabolism

Context:

• Lipoprotein(a) [Lp(a)] is a unique lipoprotein particle composed of low-density lipoprotein (LDL) and apolipoprotein(a) [Apo(a)].
• Apo(a) shares structural homology with plasminogen, the precursor to plasmin, an enzyme crucial for dissolving blood clots.
• Lp(a) is implicated in both atherogenesis and thrombosis, suggesting a dual role in cardiovascular disease.

Purpose:

• To explore the structural and functional relationship between Lp(a) and plasminogen.
• To investigate the potential role of Lp(a) in interfering with fibrinolysis.
• To examine the atherogenic potential of Lp(a) and its independent genetic regulation.

Summary:

• Lp(a) consists of LDL disulfide-bonded to Apo(a), which resembles plasminogen but lacks proteolytic activity.
• Apo(a) may interfere with fibrinolysis by competing with plasminogen, and its presence in atherosclerotic plaques suggests atherogenicity.
• Lp(a) levels are not regulated by typical LDL mechanisms, cholesterol feeding, or common lipid-lowering drugs, indicating distinct metabolic control and a strong genetic influence.

Impact:

• Lp(a) is identified as a significant, independent genetic risk factor for coronary atherosclerosis.
• Understanding Lp(a) regulation is crucial for developing targeted therapies for cardiovascular disease.
• This research highlights Lp(a) as a distinct entity from LDL, with unique implications for cardiovascular health.